Novocure Price Target Raised to $28.00/Share From $25.00 by Piper Sandler

Novocure Price Target Raised to $28.00/Share From $25.00 by Piper Sandler

Dow JonesApr 10 21:05

Piper Sandler: Reiterates the NovoCure (NVCR.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $25.00 to $28.00.

Piper Sandler: Reiterates the NovoCure (NVCR.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $25.00 to $28.00.

Zhitong FinanceApr 10 21:00

Piper Sandler Reiterates Overweight on NovoCure, Raises Price Target to $28

Piper Sandler analyst Jason Bednar reiterates NovoCure with a Overweight and raises the price target from $25 to $28.

Analyst UpgradesApr 10 20:55

Is NovoCure (NASDAQ:NVCR) Using Debt In A Risky Way?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much

Simply Wall StApr 9 01:49

Novocure Reports 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, At AACR Annual Meeting 2024

Novocure Reports 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, At AACR Annual Meeting 2024

BenzingaApr 5 19:01

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaApr 4 01:35